Sex differences in awareness and control of hypertension in France

Journal of Hypertension

Volumn 15, Issue 11, 1997, Pages 1205-1210

  Marques Vidal, Pedro ^a   Arveiler, Dominique ^b   Amouyel, Philippe ^c   Bingham, Annie ^d   Ferrières, Jean ^a,e  

^a CHU PURPAN   (France)

^b Lab d'Epidemiol et de S Pub   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d HÔPITAL BROUSSAIS   (France)

^e INSERM   (France)

Author keywords

Awareness; France; Hypertension; Men; Population survey; Prevalence; Treatment; Women

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; AWARENESS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; FEMALE; FRANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT; PATIENT ATTITUDE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URBAN POPULATION; WORLD HEALTH ORGANIZATION;

EID: 0030719875     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715110-00003     Document Type: Article

References (47)

1. Uemura K, Pisa Z: Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Statist Q 1988, 41:155-178.
2. The Principal Investigators of the MONICA Project: WHO-MONICA Project. Geographical variation in mortality from cardiovascular diseases - baseline data on selected population characteristics and cardiovascular mortality. World Health Statist Q 1987, 40:171-184.
3. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D: Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet 1986, ii:933-936.
4. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
5. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidty and mortality in the Swedish Trial in Old Patients with hypertension (STOP-hypertension). Lancet 1991, 338:1281-1285.
6. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al.: Treatment of Mild Hypertension Study. Final results. JAMA 1993, 270:713-724.
7. Dollery C: Hypertension trial results: consensus and conflicts. J Hum Hypertens 1995, 9:403-408.
8. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, et al.: The primary prevention of myocardial infarction. N Engl J Med 1992, 326:1406-1416.
9. Meredith PA: New FDA guidelines on the treatment of hypertension: comparison of different therapeutic classes according to trough/peak blood pressure responses. Arch Mal Cœur Vaiss 1994, 87:1423-1429.
10. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H: Control of blood pressure in Scotland: the rule of halves. BMJ 1990, 300:981-983.
11. Plans P, Pardell H, Salleras L: Epidemiology of cardiovascular disease risk factors in Catalonia (Spain). Eur J Epidemiol 1993, 9:381-389.
12. Dannenberg AL, Drizd T, Horan MJ, Haynes SG, Leaverton PE: Progress in the battle against hypertension. Hypertension 1987, 10:226-233
13. WHO MONICA Project (prepared by Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, et al.): Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates and case fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90:583-612.
14. Khaw KT, Barret Connor E: Sex differences, hormones, and coronary heart disease. In Coronary Heart Disease Epidemiology: From Aetiology to Public Health. Edited by Marmot M, Elliot P. Oxford: Oxford University Press, 1992: 274-286.
15. WHO MONICA Project Principal Investigators (prepared by Tunstall-Pedoe H): The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 1988, 41:105-114.
16. WHO MONICA Project: WHO MONICA Project: objectives and design. Int J Epidemiol 1989, 19:529-537.
17. WHO: The WHO MONICA Project: a worldwide monitoring system for cardiovascular diseases. World Health Statist Annu 1989, 27-149.
18. WHO: MONICA Project (prepared by Tuomilehto J and Kuulasmaa K): WHO MONICA Project: assessing CHD mortality and morbidity. Int J Epidemiol 1989, 18:S38-S45.
19. WHO MONICA Project: MONICA Manual. Geneva: World Health Organization; 1990, 1.
20. Douste-Blazy P, Ruidavets JB, Arveiler D, Bingham A, Camaré R, Schaffer P, et al.: Comparison of cardiovascular risk factor levels in two French populations: Haute-Garonne (Toulouse) and Bas-Rhin (Strasbourg). Acta Med Scand Suppl 1988, 728:137-143.
21. Marques-Vidal P, Ruidavets JB, Ferneres J, Bingham A, Cambou JP: Evolution des facteurs de risque cardiovasculaire chez l'homme en Haute-Garonne, 1985-87 et 1989-91. Résultats du Projet MONICA. Rev Epidemiol Santé Publ 1996, 44:5-13.
22. Marques-Vidal P, Amar J, Cambou JP, Chamontin B: Relationships between pulse pressure, mean blood pressure, lipids and lipoproteins in normotensive men. J Hum Hypertens 1996, 10:239-244.
23. Hense HW, Stieber J, Filipiak B, Keil U: Five-year changes in population blood pressure and hypertension prevalence. Results from the MONICA Augsburg surveys 1984/85 and 1989/90. Ann Epidemiol 1993, 3:410-416.
24. Ruidavets JB, Cambou JP, Arveiler D, Nuttens MC, Bingham A, Richard JL, et al.: Différences inter-régionales de consommation alimentaire: projet MONICA. Cah Nutr Diét 1993, 28:105-109.
25. Wagner EH, James SA, Beresford SAA, Strogatz DS, Grimson RC, Kleinbaum DG, et al.: The Edgecombe County high blood pressure control program: I. Correlates of uncontrolled hypertension at baseline. Am J Public Health 1984, 74:237-242.
26. Salomaa V, Tuomilehto J, Nissinen A, Korhonen H, Vartiainen E, Kartovaara L, et al.: The development of hypertension care in Finland from 1982 to 1987. J Hypertens 1989, 7:837-844.
27. Pica LA, Boucher MM, Grignon R: The prevalence, awareness and control of hypertension in Lavai, Québec, 1986. Can J Public Health 1990, 81:427-430.
28. Burt VL, Whelton P, Roccella EJ, Brosn C, Cutler JA, Higgins M, et al.: Prevalence of hypertension in the US adult population. Hypertension 1995, 25:305-313.
29. Nieto FJ, Alonso J, Chambless LE, Zhong M, Ceraso M, Romm FJ, et al.: Population awareness and control of hypertension and hypercholesterolemia. Arch Intern Med 1995, 155:677-684.
30. Lang T, Pariente P, Salem G, Tap D: Social, professional conditions and arterial hypertension: an epidemiological study in Dakar, Senegal. J Hypertens 1988, 6:271-276.
31. Le Regroupement de départements de santé communautaires de Montréal-métropolitain; La région de Montréal se porte-t-elle aussi bien que le reste du Québec? Résultats de l'enquÊte Santé Québec. Montréal: Santé Québec. 1989.
32. Waldron I: Sex differences in illness incidence, prognosis and mortality: issues and evidence. Soc Sci Med 1983, 17:1107-1123.
33. Vezú L, La Vecchia L, Vincenzi M: Hypertension, obesity and response to antihypertensive treatment: results of a community survey. J Hum Hypertens 1992, 6:215-220.
34. Tuomilehto J, Enlund H, Salonen J, Nissinen A: Alcohol, patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med 1984, 12:177-181.
35. Lang T, Degoulet P, Aimé F, Devries C, Jacquinet-Salord MC, Fouriaud C: Relations between alcohol consumption and hypertension prevalence and control in a French population. J Chron Dis 1987, 40:713-720.
36. Green MS, Peled I: Prevalence and control of hypertension in a large cohort of occupationally-active Israelis examined during 1985-1987: the Cordis Study. Int J Epidemiol 1992, 21:676-682.
37. Vaccarino V, Borgatta A, Gallus G, Sirtori CR: Prevalence of coronary heart disease risk factors in northern-Italian male and female employees. Eur Heart J 1995, 16:761-769.
38. Marcus AC, Siegel JM: Gender differences in the use of physician services. J Health Social Behav 1982, 23:186-197.
39. Puska P, Neittaanmäki L, Tuomilehto J: A survey of local health personnel and decision makers concerning the North Karelia Project: a community program for control of cardiovascular diseases. Prev Med 1981, 10:564-576.
40. Ménard J, Chatellier G: Limiting factors in the control of BP: why is there a gap between theory and practice? J Hum Hypertens 1995, 9:519-523.
41. Hosie J, Wiklund I: Managing hypertension in general practice: can we do better? J Hum Hypertens 1995, 9:515-518.
42. Du X, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, et al.: Case-control study of stroke and the quality of hypertension control in north west England. BMJ 1997, 314:272-276
43. Drummond M, Coyle D: Assessing the economic value of antihypertensive medicines. J Hum Hypertens 1992, 2:495-501.
44. Ménard J, Cornu P, Day M: Cost of hypertension treatment and the price of health. J Hum Hypertens 1992, 6:447-458.
45. Birkett NJ, Donner AP, Maynard MD: Assessing hypertension control in the community: the need for follow-up measurements to ensure clinical relevance. Can Med Assoc J 1987, 136:595-600.
46. O'Brien E, Mee F, Atkins N, O'Malley K: Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 1990, 336:1465-1468.
47. Conroy RM, O'Brien E, O'Malley K, Atkins N: Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn? BMJ 1993, 306:1319-1322.